Neuroleptic malignant syndrome is confusion or unresponsiveness, muscle rigidity, high body temperature, and other symptoms that occur when certain antipsychotic (neuroleptic) or anti-vomiting (antiemetic) medications are used.
Neuroleptic malignant syndrome develops in a very small number of people who are given certain types of medications.
Symptoms include a dangerously high body temperature, muscle rigidity, and agitation.
Doctors base the diagnosis on the person's symptoms and on what they find during a physical examination.
Treatment involves stopping the medication, reducing body temperature, and providing support in an intensive care unit.
(See also Overview of Heat Disorders.)
Neuroleptic malignant syndrome develops in a small number of people who are treated with antipsychotic or antiemetic medications (see table Medications That Can Cause Neuroleptic Malignant Syndrome), usually within the first few weeks of treatment. The risk of developing the syndrome while taking these medications is very low (0.1% or less). The syndrome is most common among men who, because they are agitated, are given rapidly increased doses of antipsychotics or high doses initially. Doctors are not sure why the syndrome develops.
Dawa Ambazo Zinaweza Kusababisha Neuroleptic Malignant Syndrome
Class | Medications |
|---|---|
Chlorpromazine Fluphenazine Haloperidol Loxapine Mesoridazine Molindone Perphenazine Pimozide Thioridazine Thiothixene Trifluoperazine | |
Aripiprazole Clozapine Olanzapine Paliperidone Quetiapine Risperidone Ziprasidone | |
Antiemetics (anti-nausea medications) | Domperidone Droperidol Metoclopramide Prochlorperazine Promethazine |
Dalili za Ugonjwa wa Neuroleptic Malignant
Symptoms usually develop over a few days and include:
Confusion, agitation, or coma
Muscle rigidity
A high temperature, often over 104° F (40° C)
A fast heart rate
A fast breathing rate
High or variable (labile) blood pressure
Damaged muscles release the protein myoglobin, which is excreted in the urine and turns the urine brown. This condition (myoglobinuria) can cause acute kidney injury or even kidney failure. About 5% of people die within 1 month and 15% within 1 year, even with rapid treatment.
Utambuzi wa Ugonjwa wa Neuroleptic Malignant
Typical symptoms developing in a person who is taking a medication known to cause neuroleptic malignant syndrome
Doctors suspect neuroleptic malignant syndrome when people taking a medication known to cause neuroleptic malignant syndrome develop characteristic symptoms and physical examination findings, particularly severe muscle rigidity. There are no tests that confirm the diagnosis. However, because other disorders (for example, meningitis and sepsis) can cause similar symptoms, doctors often do tests for those disorders. Doctors also do blood and urine tests to look for muscle protein breakdown and kidney injury.
Matibabu ya Ugonjwa wa Neuroleptic Malignant
Stopping the medication
Controlling the fever
Providing intensive supportive care
Various medications to control symptoms
People with neuroleptic malignant syndrome are usually treated in an intensive care unit. The medication that caused neuroleptic malignant syndrome is stopped and fever is controlled, usually by wetting (misting) and blowing air over the skin or by using special cooling blankets. People who are very agitated are given sedatives by vein. Other treatments are often used because of the severity of this condition. These include dantrolene (a muscle relaxant, to reduce fever and muscle damage) and bromocriptine (to improve nerve function).
